Essai therapeutique randomise Multicentrique en Double Insu, Comparant l'enoxaparine 40mg Versus Placebo, en Une Injection Sous-cutanee Quotidienne, Dans Les Fausses Couches spontanees recurrentes inexpliquees.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Acronyms PREFIX
- 21 Oct 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Jun 2013 Planned End Date changed from 1 Jan 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 28 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.